Sheliyan Raveenthiran

6PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersIberian languagesLiquid biopsiesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 12, 2024
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.

Matthew J Roberts, Nathan Papa, Hans Veerman

|Apr 09, 2024
UrethroNAV: the aetiology and extent of idiopathic urethral stricture in an Australian population.

Devang Desai, William Harrison, Sheliyan Raveenthiran

|Mar 17, 2022
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy.

Matthew J Roberts, Andrew Morton, Nathan Papa

|Aug 01, 2019
The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy.

Sheliyan Raveenthiran, John Yaxley, Troy Gianduzzo

|Jul 24, 2019
The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma.

Sheliyan Raveenthiran, Rachel Esler, John Yaxley

Pageof 1